Stoke Therapeutics, Inc. - Common Stock (STOK)
CUSIP: 86150R107
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,529,259
- Total 13F shares
- 61,301,002
- Share change
- +7,135,485
- Total reported value
- $828,175,296
- Put/Call ratio
- 73%
- Price per share
- $13.51
- Number of holders
- 114
- Value change
- +$96,412,204
- Number of buys
- 79
- Number of sells
- 41
Quarterly Holders Quick Answers
What is CUSIP 86150R107?
CUSIP 86150R107 identifies STOK - Stoke Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 86150R107:
Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Skorpios Trust |
13F
|
Company |
25%
|
14,443,681
|
$194,989,694 | — | 31 Mar 2024 | |
| Redmile Group, LLC |
13F
|
Company |
8.8%
|
5,073,049
|
$68,486,162 | — | 31 Mar 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
7.3%
|
4,224,838
|
$57,035,313 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
7%
|
4,025,002
|
$54,337,529 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.7%
|
3,858,463
|
$52,089,253 | — | 31 Mar 2024 | |
| Lynx1 Capital Management LP |
13F
|
Company |
6.4%
|
3,696,820
|
$49,907,070 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5.9%
|
3,368,443
|
$45,473,981 | — | 31 Mar 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
5.9%
|
3,365,744
|
$45,437,544 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
1,715,554
|
$23,159,979 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.4%
|
1,404,055
|
$18,954,743 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.8%
|
1,058,300
|
$14,287,050 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
639,807
|
$8,638,351 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1%
|
579,607
|
$7,824,695 | — | 31 Mar 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.83%
|
475,463
|
$6,418,751 | — | 31 Mar 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.74%
|
427,163
|
$5,766,701 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.72%
|
412,240
|
$5,565,240 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.65%
|
375,481
|
$5,068,997 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.52%
|
300,000
|
$4,050,000 | — | 31 Mar 2024 | |
| Eversept Partners, LP |
13F
|
Company |
0.5%
|
290,000
|
$3,915,000 | — | 31 Mar 2024 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.46%
|
263,700
|
$3,559,950 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.45%
|
260,891
|
$3,522,029 | — | 31 Mar 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.39%
|
225,496
|
$3,044,196 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.39%
|
223,038
|
$3,011,013 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.38%
|
219,765
|
$2,966,829 | — | 31 Mar 2024 | |
| Birchview Capital, LP |
13F
|
Company |
0.37%
|
210,000
|
$2,835,000 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.34%
|
193,760
|
$2,615,761 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.31%
|
178,586
|
$2,410,913 | — | 31 Mar 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.25%
|
145,000
|
$1,957,500 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.25%
|
143,351
|
$1,935,239 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.25%
|
142,458
|
$1,923,183 | — | 31 Mar 2024 | |
| Palo Alto Investors LP |
13F
|
Company |
0.22%
|
125,861
|
$1,699,124 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.21%
|
119,811
|
$1,617,449 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.19%
|
106,904
|
$1,443,204 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.17%
|
100,000
|
$1,350,000 | — | 31 Mar 2024 | |
| Maven Securities LTD |
13F
|
Company |
0.17%
|
100,000
|
$1,350,000 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.17%
|
97,508
|
$1,316,000 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
89,904
|
$1,213,705 | — | 31 Mar 2024 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.16%
|
89,783
|
$1,212,071 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
79,526
|
$1,073,602 | — | 31 Mar 2024 | |
| Fort Point Capital Partners LLC |
13F
|
Company |
0.13%
|
75,429
|
$1,018,292 | — | 31 Mar 2024 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.12%
|
67,584
|
$912,384 | — | 31 Mar 2024 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.11%
|
62,257
|
$840,470 | — | 31 Mar 2024 | |
| Stephen J. Tulipano |
3/4/5
|
Former CFO |
—
mixed-class rows
|
120,746
mixed-class rows
|
$757,722 | — | 27 Mar 2024 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.16%
|
90,663
|
$728,024 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.09%
|
51,097
|
$689,810 | — | 31 Mar 2024 | |
| LMR Partners LLP |
13F
|
Company |
0.09%
|
50,000
|
$675,000 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.09%
|
50,000
|
$675,000 | — | 31 Mar 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.08%
|
48,200
|
$650,700 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.08%
|
47,912
|
$646,812 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.08%
|
45,984
|
$620,784 | — | 31 Mar 2024 |
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock (STOK) as of Q2 2024
As of 30 Jun 2024,
Stoke Therapeutics, Inc. - Common Stock (STOK) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,301,002 shares.
The largest 10 holders included
Skorpios Trust, BlackRock Inc., Lynx1 Capital Management LP, Redmile Group, LLC, BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, MORGAN STANLEY, COWEN AND COMPANY, LLC, VANGUARD GROUP INC, and STATE STREET CORP.
This page lists
114
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
101
Q2 2024 holders
114
Holder diff
13
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.